AEVIS (AEVIS) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Nov, 2026Executive summary
9M 2026 gross revenue rose 8.2% to CHF 972.7m, driven by healthcare; net revenue was CHF 789.4m, up 0.6% like-for-like.
Financial highlights
Net revenue was down 0.1% reported from CHF 789.9m; excluding scope effects and 2025 Zermatt apartment sales, it grew 0.6%.
Independent physician fees recognized in gross revenue and passed through as third-party services totaled CHF 183.3m, versus CHF 109.3m in 9M 2025.
Outlook and guidance
Privatklinik Lindberg restructuring and improving profitability support the remainder of FY 2026; the full positive impact of the transfer is expected from FY 2027.
Partial view of Summaries dataset, powered by Quartr API
Latest events from AEVIS
- NAV per share up 6.8% to CHF 26.75; profit and margins rose; Infracore IPO boosted liquidity.AEVIS
H1 2026 - Integrated healthcare, hospitality, and real estate drive growth, margin gains, and long-term value.AEVISCMD 2026 presentation
- Acquisition for CHF 50M in shares and CHF 70M debt drives CHF 100M revenue boost in 2025.AEVISM&A announcement
- Revenue and EBITDAR surged, with net profit rebounding and strong segment growth.AEVISH1 2024
- Revenue grew 7.1% year-over-year, driven by strong healthcare, hospitality, and real estate gains.AEVISQ3 2024
- Net profit rebounded to CHF 26.5 million, with robust growth and improved capital strength.AEVISH2 2024
- Q1 2025 revenue rose 17.0% year-over-year, led by healthcare and hospitality growth.AEVISQ1 2025
- H1-2025 saw revenue up 17.9%, strong margins, and debt cut by over CHF 120m.AEVISH1 2025
- Revenue up 13.5% to CHF 1,055.1m, with deleveraging and margin improvement across segments.AEVISH2 2025